Figure 3
Figure 3. RHAUfl/fl:vav-iCre mice develop hemolytic anemia. (A) Increased erythropoietin level in blood plasma of RHAUfl/fl:vav-iCre mice. *P < .05; n = 6 for each group. (B) Blood smear examination shows the presence of spherocytes (arrows) in RHAUfl/fl:vav-iCre mice; (top) RHAUfl/fl; (bottom) RHAUfl/fl:vav-iCre. (C) Shortened lifespan of erythrocytes lacking RHAU. The half-lives of erythrocytes were determined by chasing biotinylated cells in vivo. Each dot represents the half-life value of erythrocytes from an individual mouse. The horizontal lines represent the average values, which are indicated at the bottom of the graph. *P < .05; n = 6 for RHAUfl/fl and n = 5 for RHAUfl/fl:vav-iCre.

RHAUfl/fl:vav-iCre mice develop hemolytic anemia. (A) Increased erythropoietin level in blood plasma of RHAUfl/fl:vav-iCre mice. *P < .05; n = 6 for each group. (B) Blood smear examination shows the presence of spherocytes (arrows) in RHAUfl/fl:vav-iCre mice; (top) RHAUfl/fl; (bottom) RHAUfl/fl:vav-iCre. (C) Shortened lifespan of erythrocytes lacking RHAU. The half-lives of erythrocytes were determined by chasing biotinylated cells in vivo. Each dot represents the half-life value of erythrocytes from an individual mouse. The horizontal lines represent the average values, which are indicated at the bottom of the graph. *P < .05; n = 6 for RHAUfl/fl and n = 5 for RHAUfl/fl:vav-iCre.

or Create an Account

Close Modal
Close Modal